Orum Therapeutics

Developer of cell-penetrating antibodies as oncology therapeutics

placeDaejeon, Daejeon, South Korea calendar_todayFounded 2016 groups38 employees language orumrx.com

Registered entities

Social engagement

Social engagement: 7K social following, 10 posts in the last 12 months — above the industry median.

Investor mix

21 investors on record; lead investors include IMM Investment, KB Investment, Smile Gate Investment, KTB Network.

Investor typeCountShare
Venture capital1152%
Private equity524%
Accelerator & incubator15%
Bank & private debt15%
Other / undisclosed314%

Hiring activity

Hires occasionally

1 role tracked across 1 of the last 12 months

Based on job postings tracked across public sources.

Recent activity

11 May 2026
Event
PEGSBoston2026
13 Apr 2026
Leadership hire
Board of Directors
17 Mar 2026
Event
AACR 2026
Coming soon